Nicole Dumont

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

Brooke Rothstein, Deep Joshipura, Ami Saraiya et al. · Journal of the American Academy of Dermatology · 2017 · 176 citations

Medicine, Topical Drug, Skin Pharmacology +2

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

Eva Volf, Shiu-chung Au, Nicole Dumont et al. · PubMed · 2012 · 88 citations

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

Ari M. Goldminz, Catherine D. Buzney, Noori Kim et al. · Pediatric Dermatology · 2013 · 65 citations

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Shiu‐Chung Au, Ari M. Goldminz, Noori Kim et al. · Journal of Dermatological Treatment · 2012 · 64 citations

<i>CCL20</i>and<i>IL22</i>Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis

Ari M. Goldminz, Mayte Suárez‐Fariñas, Andrew C. Wang et al. · JAMA Dermatology · 2015 · 44 citations · Full text